Synthaverse S.A.
Pharmaceutical and biotech company developing immunotherapies and medical products.
BML | WAR
Overview
Corporate Details
- ISIN(s):
- PLBMDLB00018 (+3 more)
- LEI:
- 259400OWZM67D079S374
- Country:
- Poland
- Address:
- LUBLIN UNIWERSYTECKA 10, 20-029 LUBLIN
- Website:
- https://synthaverse.com/en/
- Sector:
- Manufacturing
Description
Synthaverse S.A. is a pharmaceutical and biotechnology company that develops, manufactures, and delivers innovative medical products, including medicinal preparations, medical devices, and laboratory reagents. With a history of nearly 100 years, the company focuses on immunotherapies and leverages its own proprietary technologies. Key products include Onko BCG, a drug for bladder cancer, and the BCG 10 anti-tuberculosis vaccine. Synthaverse collaborates with scientific centers to advance its research and development, aiming to meet global quality standards and push the boundaries of medicine.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-28 17:16 |
zal02_oswadczenie_rzetelnosc_sf.pdf
|
Polish | 749.6 KB | ||
| 2025-11-28 17:16 |
zal01_skrocone-srednioroczne-sprawozdanie-finansowe-IIIq_2025.pdf
|
Polish | 2.7 MB | ||
| 2025-11-20 15:38 |
zal01_Zal_STATUT_tekst_jedn._na_28.08.2025-1.pdf
|
Polish | 688.4 KB | ||
| 2025-11-20 15:38 |
Rejestracja przez sąd zmiany statutu emitenta - Content (PL)
|
Polish | 9.1 KB | ||
| 2025-11-19 14:30 |
Zmiana daty przekazania raportu kwartalnego za okres III kwartału 2025 roku - C…
|
Polish | 952 bytes | ||
| 2025-11-13 16:45 |
Otrzymanie istotnej informacji o rejestracji na terytorium Holandii produktu le…
|
Polish | 1.4 KB | ||
| 2025-11-05 16:57 |
Informacja o uchyleniu przez sąd zabezpieczenia roszczenia - Content (PL)
|
Polish | 2.7 KB | ||
| 2025-10-23 10:26 |
zal01_pdf_887150.pdf
|
Polish | 9.0 KB | ||
| 2025-10-23 10:26 |
Powiadomienie o transakcji na akcjach Emitenta - Content (PL)
|
Polish | 349 bytes | ||
| 2025-10-16 12:18 |
Podpisanie protokołu odbioru linii technologicznej w Zakładzie produkcyjnym Onk…
|
Polish | 2.1 KB | ||
| 2025-09-30 22:10 |
zal03_Synthaverse_30.06.2025_Raport_z_przegladu_srodrocznego_skroconego_JSF_MSS…
|
Polish | 398.4 KB | ||
| 2025-09-30 22:10 |
zal02_sprawozdanie_zarzadu_z_dzialalnosci_spolki_za_I_polrocze_2025.pdf
|
Polish | 1.5 MB | ||
| 2025-09-30 22:10 |
zal01_skrocone_srodroczne_sprawozdanie_finansowe_za_okres_od_01_01_2025_do_30_0…
|
Polish | 2.7 MB | ||
| 2025-09-29 08:35 |
Zawarcie istotnej umowy handlowej - Content (PL)
|
Polish | 5.2 KB | ||
| 2025-09-17 14:03 |
Informacja o wniesieniu powództwa o uchylenie lub stwierdzenie nieważności uchw…
|
Polish | 4.1 KB |
Automate Your Workflow. Get a real-time feed of all Synthaverse S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Synthaverse S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Synthaverse S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
